https://www.selleckchem.com/pr....oducts/Tigecycline.h
Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson's disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in routine clinical practice, as recommended by the European Medicines Agency. To describe the occurrence of adverse events in PD patients treated with safinamide in real-life conditions. The SYNAPSES trial is an observational, European, multicenter, retrospective-prospective cohort study. Patients were
Like
Comment
Share
